Free Trial

Kirby (KEX) Projected to Post Quarterly Earnings on Thursday

Kirby logo with Transportation background

Kirby (NYSE:KEX - Get Free Report) is anticipated to issue its Q2 2025 quarterly earnings data before the market opens on Thursday, July 31st. Analysts expect the company to announce earnings of $1.59 per share and revenue of $851.94 million for the quarter.

Kirby (NYSE:KEX - Get Free Report) last announced its earnings results on Thursday, May 1st. The shipping company reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.06. Kirby had a return on equity of 9.81% and a net margin of 9.02%. The business had revenue of $785.66 million for the quarter, compared to analysts' expectations of $824.12 million. During the same period last year, the firm posted $1.19 earnings per share. The business's revenue for the quarter was down 2.8% on a year-over-year basis. On average, analysts expect Kirby to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Kirby Stock Performance

Shares of NYSE KEX traded up $2.37 during trading on Friday, hitting $118.36. The company had a trading volume of 360,277 shares, compared to its average volume of 481,108. The stock has a 50 day simple moving average of $113.45 and a 200 day simple moving average of $106.06. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.96 and a current ratio of 1.58. Kirby has a 12 month low of $83.94 and a 12 month high of $132.21. The firm has a market capitalization of $6.64 billion, a P/E ratio of 23.44, a price-to-earnings-growth ratio of 1.04 and a beta of 0.96.

Institutional Trading of Kirby

A hedge fund recently raised its stake in Kirby stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Kirby Corporation (NYSE:KEX - Free Report) by 152.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 182,565 shares of the shipping company's stock after acquiring an additional 110,320 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 0.33% of Kirby worth $18,441,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 96.15% of the company's stock.

Analysts Set New Price Targets

Separately, Bank of America raised their price objective on Kirby from $116.00 to $125.00 and gave the stock a "buy" rating in a research note on Friday, May 16th.

Read Our Latest Report on Kirby

About Kirby

(Get Free Report)

Kirby Corporation operates domestic tank barges in the United States. Its Marine Transportation segment provides marine transportation service and towing vessel transporting bulk liquid product, as well as operates tank barge throughout the Mississippi River System, on the Gulf Intracoastal Waterway, coastwise along three United States coasts, and in Alaska and Hawaii.

See Also

Earnings History for Kirby (NYSE:KEX)

Should You Invest $1,000 in Kirby Right Now?

Before you consider Kirby, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kirby wasn't on the list.

While Kirby currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines